LGND
Ligand Pharmaceuticals Inc - Class B
$203.61
+2.01% (+$4.02)
Volume
234,907
52W High
$227.92
52W Low
$93.58
Market Cap
$3.77B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.65
Whisper EPS
$1.83
10.7% above consensus
Last Quarter
$2.02
Current Streak
2 Beats
Avg Surprise (4Q)
+4.15%
Next Earnings Report
Reports in 36 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Mar 4, 2026
1-Day:
-1.28%
5-Day:
-0.38%
Q4 2025
Feb 26, 2026
1-Day:
+1.09%
5-Day:
+4.11%
Q3 2025
Nov 6, 2025
1-Day:
-2.76%
5-Day:
+0.23%
Q2 2025
Aug 8, 2025
5-Day:
+3.96%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $59.7M | +39.4% | 143.6% | 33.6% | $44.8M |
| Q3'25 | $115.5M | +122.9% | 78.5% | 47.6% | $117.3M |
| Q2'25 | $47.6M | +14.7% | 93.9% | 17.7% | $4.8M |
| Q1'25 | $45.3M | +46.3% | 89.3% | -79.9% | -$42.5M |
| Q4'24 | $42.8M | +52.4% | 93.4% | -22.5% | -$31.1M |
| Q3'24 | $51.8M | +57.6% | 75.9% | 6.1% | -$7.2M |
| Q2'24 | $41.5M | +57.5% | 136.9% | -46.0% | -$51.9M |
| Q1'24 | $31.0M | -29.6% | 64.3% | 9.7% | $86.1M |
Company Information
Symbol
LGND
Company
Ligand Pharmaceuticals Inc - Class B
Market Cap
$3.77B
Next Earnings
May 13, 2026